CoinScoopCanary Capital Updates Staked Injective ETF Filing with SEC
Canary Capital has amended its prospectus for a staked Injective ETF with the US Securities and Exchange Commission, aiming to provide regulated exposure to Injective and staking rewards. Following the news, the price of $INJ rose 5% to $8.60.
Summaries are written by AI from the original article. Not investment advice.